Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer.
Danilovic DLS, Castro G Jr, Roitberg FSR, Vanderlei FAB, Bonani FA, Freitas RMC, Coura-Filho GB, Camargo RY, Kulcsar MA, Marui S, Hoff AO.
Danilovic DLS, et al.
Arch Endocrinol Metab. 2018 Jun;62(3):370-375. doi: 10.20945/2359-3997000000046. Epub 2018 May 17.
Arch Endocrinol Metab. 2018.
PMID: 29791660
Free PMC article.